
Thi D. Duong
Articles
-
Jan 26, 2024 |
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 26, 2024MISSISSAUGA, Ontario, Canada — HOYA Vision Care is releasing a new Canadian public awareness campaign geared towards highlighting the benefits of MiYOSMART spectacle lenses for children with myopia. The campaign will drive awareness about the short- and long-term impacts of myopia progression among children.
-
Jan 26, 2024 |
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 25, 2024PRINCETON, N.J. — Hoot Myopia Care has released a new feature for ECPs that will help automate the process of administering pediatric referrals for myopia management. The program, Hoot Referrals, will work to assist optometrists specializing in myopia to increase referrals from pediatricians.
-
Jan 25, 2024 |
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 25, 2024ST. LOUIS — The World Council of Optometry (WCO) will be hosting “Myopia Management: From Theory to Practice,” its first Latin America-based virtual event, on February 20, 22, 27, and 29, 2024. Now, the organization has announced the speakers for the event. Speakers include:Sandra S.
-
Jan 24, 2024 |
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 24, 2024DUBLIN, Ireland — Ocumetra has released new updates to its mEYE Guide and mEYE Gauge software for ECPs. The revamped platform introduces a sleek design while maintaining a user-friendly interface. Notably, data entry for both mEYE Guide and mEYE Gauge has been streamlined into a single form, optimizing chair time efficiency in practice. Among the new features is axial length analysis using either estimated or measured axial length data.
-
Jan 22, 2024 |
reviewofmm.com | Thomas Naduvilath |Huy Tran |Huy Trần |Thi D. Duong
January 22, 2024LAS VEGAS — Visioneering Technologies Inc. (VTI) is sharing results from its ongoing PROTECT Trial (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial). The PROTECT Trial is a multi-national, double-masked, randomized controlled trial designed to demonstrate the safety and effectiveness of NaturalVue Multifocal 1 Day contact lenses (NVMF) for myopia progression control in children.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →